EVAg

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the N (CUB) gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

anti-Zaire ebolavirus (EBOV-Zaire) VP30

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp (IP2/IP4) gene, for 100 Rxns (Target designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp gene, for 25 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

anti-Gn or Gc protein of Tula orthohantavirus, clone 4G10A3, cell culture supernatant

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the E gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

anti-GP 3 of Porcine reproductive and respiratory syndrome virus (PRRSV) murine monoclonal antibody, clone Hy P10-c40-c1 (CCLV-RIE 1167)

anti-N of Porcine reproductive and respiratory syndrome virus (PRRSV) murine monoclonal antibody, clone Hy P10-a1-10-c19 (CCLV-RIE 1168)

anti-GP 5 of Porcine reproductive and respiratory syndrome virus (PRRSV) strain I10, Hy P10-b38-c16 (CCLV-RIE 1089)

anti-GP 5 of Porcine reproductive and respiratory syndrome virus (PRRSV) strain I10 murine monoclonal antibody, clone Hy P10-a46-15 (CCLV-RIE 1175)

anti-GP 4 of Porcine reproductive and respiratory syndrome virus (PRRSV) murine monoclonal antibody, clone Hy P11.B2-b17 (CCLV-RIE 0375)

24 pad nitrocellulose glass slides with a set of 33 HA1 proteins printed on each pad. The slides can be used for HA antibody profiling for group level assessment of exposures to influenza viruses in small sample volumes from humans and animals (birds, horses, pigs, bats, carnivores a.o.) in very small volumes of serum (10 μL). Each slides can be used for 24 sera. Scanning and analysis services are included.

Hybridoma cell culture supernatant containing anti-Bat influenza H17N10 antibodies; cross-reactive with avian Influenza virus, targeted antigen: NP; clone: 4B4C2; immunization antigen: recombinant NP Protein of H17N10

Hybridoma cell culture supernatant containing anti-Bat influenza H17N10 antibodies; targeted antigen: NP; clone: 2E3A1; immunization antigen: recombinant NP Protein of H17N10

Hybridoma cell culture supernatant containing anti-Schmallenberg orthobunyavirus antibodies; targeted antigen: NSm; clone: 2C5C3C; immunization antigen: recombinant NSm Protein of SBV

Hybridoma cell culture supernatant containing anti-Schmallenberg orthobunyavirus antibodies; targeted antigen: Gc; clone: 5E1A3; immunization antigen: recombinant Gc Protein of SBV

Hybridoma cell culture supernatant containing anti-California encephalitis orthobunyavirus (La Crosse virus) antibodies; targeted antigen: Gc; clone: 4C12A1; immunization antigen: recombinant Gc Protein of LACV

Hybridoma cell culture supernatant containing anti-atypical pestivirus "Bungowannah" antibodies; targeted antigen: ERNS; clone: 44E2; immunization antigen: inactivated atypical pestivirus strain "Bungowannah"

Hybridoma cell culture supernatant containing anti-atypical pestivirus "Bungowannah" antibodies; targeted antigen: E1E2; clone: 30E1; immunization antigen: inactivated atypical pestivirus strain "Bungowannah"

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: NSm; clone: 1E4C2 (IgG1); immunization antigen: recombinant NSm protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: NP; clone: 22E6 (IgG1 κ); immunization antigen: recombinant N protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: glykoprotein Gc; clone: 9F3 (IgG2a); immunization antigen: recombinant Gc protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: glykoprotein Gn; clone: 130 (IgG2a, κ); immunization antigen: recombinant Gn protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: NSm; clone: 1E9A2 (IgG2a); immunization antigen: recombinant NSm protein

Anti-Rift Valley Fever Virus; RVFV; NSs reference constisting of 6 different antibodies